GARY GATHRIGHT: Open Payments
NPI 1851838866 · FEASTERVILLE TREVOSE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,444 in 46 payments from 9 companies in 2025. Trend: 2023 $1,064 · 2024 $1,967 · 2025 $1,444
Food & beverage: $1,444
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $367 |
| Neurocrine BioSciences, Inc. | 3 | $251 |
| Braeburn Inc. | 7 | $219 |
| Otsuka America Pharmaceutical, Inc. | 4 | $176 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $165 |
| Lilly USA, LLC | 1 | $121 |
| Indivior Inc. | 4 | $62 |
| Bausch Health US, LLC | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
Products named: VRAYLAR, INGREZZA, BRIXADI, REXULTI, CAPLYTA, ZEPBOUND, SUBLOCADE, MAVYRET.
Industry payments across PA — which companies pay providers there.
